Skip to main content

Influenza Prophylaxis News (Page 3)

Related terms: Flu Prevention

FDA Approves Flucelvax - First Seasonal Influenza Vaccine Manufactured Using Cell Culture Technology

November 20, 2012 – The U.S. Food and Drug Administration announced today the approval of Flucelvax, the first seasonal influenza vaccine licensed in the United States produced using cultured animal...

FDA Licenses Fluzone Intradermal - Sanofi Pasteur's New Influenza Vaccine Delivered by Intradermal Microinjection

Swiftwater, Pa — May 10, 2011 /PRNewswire/ — Sanofi Pasteur, the vaccines division of Sanofi announced today the U.S. Food and Drug Administration (FDA) has approved the company's supplemental bio...

FDA Approves a High Dose Seasonal Influenza Vaccine Specifically Intended for People Ages 65 and Older

The U.S. Food and Drug Administration today approved Fluzone High-Dose, an inactivated influenza virus vaccine for people ages 65 years and older to prevent disease caused by influenza virus subtypes...

FDA Approves Agriflu Seasonal Influenza Vaccine

ROCKVILLE, Md., Nov. 27, 2009--The U.S. Food and Drug Administration today approved Agriflu for people ages 18 years and older to prevent disease caused by influenza virus subtypes A and B. Agriflu,...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Vaccination and Prophlaxis

Related drug support groups

amantadine